Market Place
Sourcing Support
Brenus Pharma and InSphero Develop 3D Tumor Spheroids Confirming
19 Jun 2025 //
BUSINESSWIRE
Brenus Reveals STC-1010 Preclinical Data at AACR 2025
07 May 2025 //
BUSINESSWIRE
Brenus Pharma`s POC Results in Scientific Frontiers in Oncology
07 Nov 2024 //
BUSINESSWIRE
Brenus Pharma Raises $25M for Cancer Vaccine Trials
18 Sep 2024 //
BUSINESSWIRE
Brenus Pharma Wins French Tech Saint-Etienne Lyon`s BIG Start-up Award
03 Jul 2024 //
BUSINESSWIRE
Brenus Pharma Graduates from Creative Destruction Lab`s Global Cancer Stream
27 Jun 2024 //
BUSINESSWIRE
ASCO 2024: Brenus presenteert "BreAK-CRC" (FIH) fase I/IIA-studie van STC-1010
13 Jun 2024 //
BUSINESSWIRE
Brenus Pharma Presents STC-1010 Efficacy Data at AACR 2024
09 Apr 2024 //
BUSINESSWIRE
Brenus Pharma Receives €5 Million for Its Anticancer Vaccine Immunotherapy
22 Jan 2024 //
BUSINESSWIRE
Brenus Joins the PSCC to Collaborate at the Heart of Innovation in Oncology
14 Dec 2023 //
BUSINESSWIRE
Brenus unveils promising pre-clinical results extrapolating human conditions
28 Sep 2023 //
BUSINESSWIRE
Brenus Pharma announces its international Scientific Committee
07 Jun 2023 //
BUSINESSWIRE
Brenus Pharma Unveils Groundbreaking Preclinical Results For STC-10101
27 Apr 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.